Recent Blog Posts

View Post: ANTI-CANCER
2 Dec 2009
Slide 66: CANCER CHEMOTHERAPY ACRONYMS • ABVD : Doxorubicin (adriamycin), bleomycin, vinblastine, dacarbazine • CHOP :Cyclophosphamide, doxorubicin (hydroxydaunorubicin), vincristine (oncovin), Prednisone • MOPP : Melchlorethamine, ...
View Blog: Recent plicks from myplick.com - http://www.myplick.com/

---

View Post: Scrip News - Japanese trial to look at doxorubicin combination for ...
24 Nov 2009
Janssen Pharmaceutical in Japan is to investigate the combination use of its anticancer drug Doxil (liposomal doxorubicin) for ovarian cancer in a research collaboration with a leading local university. The safety and efficacy of the ...
View Blog: Scrip News - Home - RSS - http://www.scripnews.com/home/

---

View Post: Docetaxel and pegylated liposomal doxorubicin combination as first ...
24 Nov 2009 by de la Fouchardiere, C., Largillier, R.,...  
Background: This phase II study evaluated the clinical benefit of pegylated liposomal doxorubicin (PLD) and docetaxel (Taxotere) as first-line therapy for metastatic breast cancer (MBC). Patients and methods: MBC patients were enrolled ...
View Blog: Annals of Oncology - recent issues - http://annonc.oxfordjournals.org/

---

View Post: Diagnosis and Treatment of Epithelial Ovarian Cancer By Matthew ...
15 hours ago by Matthew Sirott  
There are also a number of single agent drugs with activity in ovarian cancer. These include altretamine, bevacizumab, docetaxel, etoposide, gemcitabine, liposomal doxorubicin, paclitaxel, tamoxifen, topotecan and vinorelbine. ...
View Blog: Medical Business Articles At Isnare.com - http://www.isnare.com/?aid=398493&ca=Medical+Business

---

View Post: Reversibly Stabilized Multifunctional Dextran Nanoparticles ...
23 Nov 2009 by Yu-Ling Li, Li Zhu, Zhaozhong Liu, Ru Cheng,...  
DOI: 10.1002/anie.200904260. Reversibly Stabilized Multifunctional Dextran Nanoparticles. Efficiently Deliver Doxorubicin into the Nuclei of Cancer Cells**. Yu-Ling Li, Li Zhu, Zhaozhong Liu, Ru Cheng, Fenghua Meng,* Jing-Hao Cui, ...
View Blog: Angewandte Chemie International Edition - http://dx.doi.org/10.1002%2F(ISSN)1521-3773

---

View Post: p34SEI-1 Inhibits Doxorubicin-Induced Senescence through a Pathway ...
17 Nov 2009 by Lee, SLO, Hong, S.-W., Shin, J.-S., Kim,...  
1Research Center for Women's Diseases, Division of Biological Sciences, Sookmyung Women's University, 2Department of Anatomy and Tumor Immunity Medical Research Center, 3Cancer Research Institute, Seoul National University College of ...
View Blog: Molecular Cancer Research current issue - http://mcr.aacrjournals.org/

---

View Post: iNOS activity is necessary for the cytotoxic and immunogenic ...
18 Nov 2009 by Chiara Riganti  
Background: Doxorubicin is one of the few chemotherapeutic drugs able to exert both cytotoxic and pro-immunogenic effects against cancer cells. Following the drug administration, the intracellular protein calreticulin is translocated ...
View Blog: Molecular Cancer - Latest Articles - http://www.molecular-cancer.com/

---

View Post: Phase I Combination Study of Trabectedin and Doxorubicin in ...
16 Oct 2008 by Blay, J.-Y., von Mehren, M., Samuels, BL,...  
Authors' Affiliations:1CONTICANET and UJOMM Hôpital Edouard Herrot, 2Centre Léon Bérard, Lyon, France; 3Fox Chase Cancer Center, Philadelphia, Pennsylvania; 4North Idaho Cancer Center, Coeur d'Alene, Idaho; 5St. Vincent's Comprehensive ...
View Blog: Clinical Cancer Research recent issues - http://clincancerres.aacrjournals.org/

---

View Post: Liver Cancer Clinical Trial: Transarterial Chemoembolization With ...
6 Nov 2009
It is not yet known whether transarterial chemoembolization with doxorubicin is more effective when given alone or when given together with everolimus in treating patients with liver cancer. PURPOSE: This randomized phase I/II trial is ...
View Blog: Clinical Trials Updates During the Last 7 Days - http://clinicaltrialsfeeds.org/clinical-trials/r...

---